BACKGROUND & AIMS: There is observational and clinical evidence that indicates that sex hormones affect development of colorectal cancer in men and women. However, the relationship between endogenous sex hormone levels and colorectal cancer is unclear. METHODS: We collected data on lifestyle, medical history, and diet (through 2008), along with blood samples, from the Nurses' Health Study, the Women's Health Study, the Health Professional Follow-up Study, and the Physicians' Health Study II. We measured plasma levels of estrone, estradiol, testosterone, sex hormone binding globulin (SHBG), and C-peptide among 730 women (293 cases of colorectal cancer and 437 healthy individuals as controls) and 1158 men (439 colorectal cancer cases and 719 controls) and used unconditional logistic regression to estimate relative risks (RRs) and 95% confidence intervals. All statistical tests were 2-sided. RESULTS: Total testosterone, SHBG, and the ratio of estradiol to testosterone were associated with colorectal cancer in men after adjustments for matching and risk factors for colorectal cancer, including body mass index and plasma levels of C-peptide. The RRs in the highest relative to the lowest quartile were 0.62 for testosterone (95% confidence interval, 0.40-0.96), 0.65 for SHBG (95% confidence interval, 0.42-0.99), and 2.63 for the ratio (95% confidence interval, 1.58-4.36) (P values for trend ≤ .02). However, in women, only the ratio of estradiol to testosterone was (inversely) associated with colorectal cancer after adjustments for all factors (RR, 0.43; 95% confidence interval, 0.22-0.84; P value for trend = .03). CONCLUSIONS: On the basis of combined data from 4 population studies, there appears to be an association between levels of sex hormones and colorectal cancer risk in men. There also appears to be an inverse association between the ratio of estradiol to testosterone and colorectal cancer in postmenopausal women.
BACKGROUND & AIMS: There is observational and clinical evidence that indicates that sex hormones affect development of colorectal cancer in men and women. However, the relationship between endogenous sex hormone levels and colorectal cancer is unclear. METHODS: We collected data on lifestyle, medical history, and diet (through 2008), along with blood samples, from the Nurses' Health Study, the Women's Health Study, the Health Professional Follow-up Study, and the Physicians' Health Study II. We measured plasma levels of estrone, estradiol, testosterone, sex hormone binding globulin (SHBG), and C-peptide among 730 women (293 cases of colorectal cancer and 437 healthy individuals as controls) and 1158 men (439 colorectal cancer cases and 719 controls) and used unconditional logistic regression to estimate relative risks (RRs) and 95% confidence intervals. All statistical tests were 2-sided. RESULTS: Total testosterone, SHBG, and the ratio of estradiol to testosterone were associated with colorectal cancer in men after adjustments for matching and risk factors for colorectal cancer, including body mass index and plasma levels of C-peptide. The RRs in the highest relative to the lowest quartile were 0.62 for testosterone (95% confidence interval, 0.40-0.96), 0.65 for SHBG (95% confidence interval, 0.42-0.99), and 2.63 for the ratio (95% confidence interval, 1.58-4.36) (P values for trend ≤ .02). However, in women, only the ratio of estradiol to testosterone was (inversely) associated with colorectal cancer after adjustments for all factors (RR, 0.43; 95% confidence interval, 0.22-0.84; P value for trend = .03). CONCLUSIONS: On the basis of combined data from 4 population studies, there appears to be an association between levels of sex hormones and colorectal cancer risk in men. There also appears to be an inverse association between the ratio of estradiol to testosterone and colorectal cancer in postmenopausal women.
Authors: A J Alberg; G B Gordon; S C Hoffman; G W Comstock; K J Helzlsouer Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-05 Impact factor: 4.254
Authors: Jennifer H Lin; Teppei Morikawa; Andrew T Chan; Aya Kuchiba; Kaori Shima; Katsuhiko Nosho; Gregory Kirkner; Shumin M Zhang; Joann E Manson; Edward Giovannucci; Charles S Fuchs; Shuji Ogino Journal: Cancer Res Date: 2012-04-17 Impact factor: 12.701
Authors: S E Hankinson; J E Manson; D Spiegelman; W C Willett; C Longcope; F E Speizer Journal: Cancer Epidemiol Biomarkers Prev Date: 1995-09 Impact factor: 4.254
Authors: Rowan T Chlebowski; Jean Wactawski-Wende; Cheryl Ritenbaugh; F Allan Hubbell; Joao Ascensao; Rebecca J Rodabough; Carol A Rosenberg; Victoria M Taylor; Randall Harris; Chu Chen; Lucile L Adams-Campbell; Emily White Journal: N Engl J Med Date: 2004-03-04 Impact factor: 91.245
Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene Journal: JAMA Date: 2002-07-17 Impact factor: 56.272
Authors: Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum Journal: Nutr Cancer Date: 2015-08-28 Impact factor: 2.900
Authors: Joshua Petimar; Stephanie A Smith-Warner; Bernard Rosner; Andrew T Chan; Edward L Giovannucci; Fred K Tabung Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-06-24 Impact factor: 4.254
Authors: Mingyang Song; Frank B Hu; Donna Spiegelman; Andrew T Chan; Kana Wu; Shuji Ogino; Charles S Fuchs; Walter C Willett; Edward L Giovannucci Journal: Cancer Prev Res (Phila) Date: 2015-04-30
Authors: Fred K Tabung; Teresa T Fung; Jorge E Chavarro; Stephanie A Smith-Warner; Walter C Willett; Edward L Giovannucci Journal: Int J Cancer Date: 2016-11-14 Impact factor: 7.396
Authors: Roni T Falk; Cher M Dallal; James V Lacey; Douglas C Bauer; Diana S M Buist; Jane A Cauley; Trisha F Hue; Andrea Z LaCroix; Jeffrey A Tice; Ruth M Pfeiffer; Xia Xu; Timothy D Veenstra; Louise A Brinton Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-23 Impact factor: 4.254
Authors: Camila M Lopes-Ramos; Marieke L Kuijjer; Shuji Ogino; Charles S Fuchs; Dawn L DeMeo; Kimberly Glass; John Quackenbush Journal: Cancer Res Date: 2018-10-01 Impact factor: 12.701
Authors: Song-Yi Park; Lynne R Wilkens; Laurence N Kolonel; Brian E Henderson; Loïc Le Marchand Journal: Int J Cancer Date: 2016-05-14 Impact factor: 7.396
Authors: Mingyang Song; Xuehong Zhang; Kana Wu; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Andrew T Chan Journal: Cancer Prev Res (Phila) Date: 2013-07-19
Authors: Chun-Han Lo; Xiaosheng He; Dong Hang; Kana Wu; Shuji Ogino; Andrew T Chan; Edward L Giovannucci; Mingyang Song Journal: Int J Cancer Date: 2020-03-31 Impact factor: 7.396